Table 6 Results of steroid administration
From: Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
| Â | Cases steroids used | Resolution | Partial resolution |
|---|---|---|---|
Uveitis (n = 134) | 124 (92.5%) | 82/124 (66.1%) | 20/124 (16.1%) |
Neuro-ophthalmic disordes (n = 71) | 67 (94.3%) | 26/67 (38.3%) | 20/67 (29.9%) |
Orbit and ocular adnexa (n = 33) | 31 (93.9%) | 20/31 (64.5%) | 7/31 (22.6%) |
Cornea and ocular adnexa (n = 30) | 25 (83.3%) | 13/25 (52.0%) | 9/25 (36.0%) |
Retina (n = 26) | 13 (50.0%) | 4/13 (30.8%) | 3/13 (23.1%) |